MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
GeneticVariation
|
disease |
BEFREE |
Defects in muscle, skeletal, receptor tyrosine kinase (MuSK) cause two distinct phenotypes: fetal akinesia with multiple congenital anomalies (Fetal akinesia deformation sequence [MIM:208150]) and early onset congenital myasthenia (myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency [MIM:616325]).
|
30719842 |
2019 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
MuSK: a new target for lethal fetal akinesia deformation sequence (FADS).
|
25612909 |
2015 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
|
24183479 |
2014 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
|
23326516 |
2013 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
|
20371544 |
2010 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes.
|
19949040 |
2009 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes.
|
19949040 |
2009 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
Biomarker
|
disease |
MGD |
A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
|
18718936 |
2008 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
MUSK, a new target for mutations causing congenital myasthenic syndrome.
|
15496425 |
2004 |
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
|
0.810 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Pena-Shokeir syndrome type I
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Defects in muscle, skeletal, receptor tyrosine kinase (MuSK) cause two distinct phenotypes: fetal akinesia with multiple congenital anomalies (Fetal akinesia deformation sequence [MIM:208150]) and early onset congenital myasthenia (myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency [MIM:616325]).
|
30719842 |
2019 |
Pena-Shokeir syndrome type I
|
0.730 |
Biomarker
|
disease |
BEFREE |
Here we identify MUSK as a novel cause of lethal FADS.
|
25537362 |
2015 |
Pena-Shokeir syndrome type I
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
Here we identify MUSK as a novel cause of lethal FADS.
|
25537362 |
2015 |
Pena-Shokeir syndrome type I
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
MuSK: a new target for lethal fetal akinesia deformation sequence (FADS).
|
25612909 |
2015 |
Pena-Shokeir syndrome type I
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Here we identify MUSK as a novel cause of lethal FADS.
|
25537362 |
2015 |
Pena-Shokeir syndrome type I
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Here we identify MUSK as a novel cause of lethal FADS.
|
25537362 |
2015 |
Pena-Shokeir syndrome type I
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
MuSK: a new target for lethal fetal akinesia deformation sequence (FADS).
|
25612909 |
2015 |
Pena-Shokeir syndrome type I
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
MuSK: a new target for lethal fetal akinesia deformation sequence (FADS).
|
25612909 |
2015 |
Pena-Shokeir syndrome type I
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Pena and Shokeir described the phenotype of two sisters in 1974, and subsequently their features have become recognized as a sequence of deformational changes related to decreased or absent fetal movement (fetal akinesia deformation sequence [FADS]), because of the work of Moessinger (1983).
|
19645055 |
2009 |
Pena-Shokeir syndrome type I
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Pena-Shokeir syndrome type I
|
0.730 |
Biomarker
|
disease |
HPO |
|
|
|
Pena-Shokeir syndrome type I
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
Pena-Shokeir syndrome type I
|
0.730 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Myasthenic Syndromes, Congenital
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Defects in muscle, skeletal, receptor tyrosine kinase (MuSK) cause two distinct phenotypes: fetal akinesia with multiple congenital anomalies (Fetal akinesia deformation sequence [MIM:208150]) and early onset congenital myasthenia (myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency [MIM:616325]).
|
30719842 |
2019 |